NB Stock Analysis: NioCorp Developments Common | NASDAQ
Other Industrial Metals & Mining | NASDAQ, USA | Market Cap: 665m USD | 12M Return: 51% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.3M
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NioCorp Developments Ltd. (NASDAQ: NB) is a U.S.-based mineral exploration and development company focused on the Elk Creek project in Johnson County, southeast Nebraska. The project targets niobium, scandium, and titanium deposits and encompasses a 227-acre parcel with associated mineral rights, plus 80 acres of surface rights, 40 acres of mineral rights, and an optioned land package covering 1,272 acres. The company also conducts research and development on aluminum-scandium alloys and related applications.
The company was incorporated in 1987, originally as Quantum Rare Earth Developments Corp., and adopted its current name in March 2013. It is headquartered in Centennial, Colorado, and trades on NASDAQ as a small-cap stock in the Materials sector, specifically within the Diversified Metals & Mining sub-industry. NioCorp began public trading in March 2023.
The companys focus areas reflect demand for critical and strategic metals: niobium is primarily used as a steel additive to produce high-strength low-alloy (HSLA) steels for pipelines, automotive components, and construction, while scandium is valued for aerospace alloys, solid oxide fuel cells, and lightweight structural applications. Titanium has broad use across aerospace, medical devices, and industrial equipment. As a single-asset developer, NioCorps business model centers on advancing the Elk Creek project through permitting, financing, and ultimately construction and production, which means its value is heavily tied to project execution milestones and commodity price trends.
- Elk Creek niobium project financing advances with EXIM Bank loan
- Scandium demand rises as aluminum-scandium alloy applications expand
- Niobium supply concentration concerns boost Elk Creek strategic importance
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: -0.22 > 0.02 and ΔFCF/TA 20.33 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.04 > 3% & CFO -16.7m > Net Income -49.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 31.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (136.2m) vs 12m ago 230.7% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 0.0%; Δ 0.0% > 0%) |
| Interest Coverage Ratio: -706.5 > 6 (EBIT TTM -33.9m / Interest Expense TTM 48.0k) |
| A: 0.87 (Total Current Assets 423.5m - Total Current Liabilities 13.6m) / Total Assets 469.0m |
| B: -0.47 (Retained Earnings -221.9m / Total Assets 469.0m) |
| C: -0.14 (EBIT TTM -33.9m / Avg Total Assets 243.7m) |
| D: 12.59 (Book Value of Equity 435.4m / Total Liabilities 34.6m) |
| Altman-Z'' = 16.48 = AAA |
As of July 11, 2026, the stock is trading at USD 4.62 with a total of 2,064,895 shares traded. Over the past week, the price has changed by -2.53%, over one month by -4.55%, over three months by -4.15% and over the past year by +50.98%.
Current recommended Stop Loss: 4.10 (which is 11.3% or 1.5 ATR below the current price).
NioCorp Developments Common has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NB.
- StrongBuy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 11.7 | 153.2% |
P/B = 1.5682
Revenue TTM = 0.0 USD
EBIT TTM = -33.9m USD
EBITDA TTM = -33.7m USD
Long Term Debt = 217k USD (estimated: total debt 379k - short term 162k)
Short Term Debt = 162k USD (from shortTermDebt, last quarter)
Debt = 379k USD (from shortLongTermDebtTotal, last quarter) (leases 379k already included)
Net Debt = -420.9m USD (calculated: Debt 379k - CCE 421.3m)
Enterprise Value = 244.5m USD (665.3m + Debt 379k - CCE 421.3m)
Interest Coverage Ratio = -706.5 (Ebit TTM -33.9m / Interest Expense TTM 48.0k)
EV/FCF = -2.33x (Enterprise Value 244.5m / FCF TTM -105.0m)
FCF Yield = -42.94% (FCF TTM -105.0m / Enterprise Value 244.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 3.00k) / Revenue TTM)
Tobins Q-Ratio = 0.52 (Enterprise Value 244.5m / Total Assets 469.0m)
Interest Expense / Debt = 12.66% (Interest Expense 48.0k / Debt 379k)
Taxrate = 0.0% (0.0 / 325k)
NOPAT = -33.9m (EBIT -33.9m * (1 - 0.00%)) [loss with tax shield]
Current Ratio = 25.47 (Total Current Assets 423.5m / Total Current Liabilities 16.6m)
Debt / Equity = 0.00 (Debt 379k / totalStockholderEquity, last quarter 435.4m)
Debt / EBITDA = 12.48 (negative EBITDA) (Net Debt -420.9m / EBITDA -33.7m)
Debt / FCF = 4.01 (negative FCF - burning cash) (Net Debt -420.9m / FCF TTM -105.0m)
Total Stockholder Equity = 231.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -20.31% (Net Income -49.5m / Total Assets 469.0m)
RoE = -21.43% (Net Income TTM -49.5m / Total Stockholder Equity 231.0m)
RoCE = -14.67% (EBIT -33.9m / Capital Employed (Equity 231.0m + L.T.Debt 217k))
RoIC = -7.45% (negative operating profit) (NOPAT -33.9m / Invested Capital 455.5m)
WACC = 8.06% (E(665.3m)/V(665.7m) * Re(8.06%) + D(379k)/V(665.7m) * Rd(12.66%) * (1-Tc(0.0)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.88 | Cagr: 87.10%
[DCF] Fair Price = unknown (Cash Flow -105.0m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.63 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: 0.0 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.04 | Chg30d=+42.86% | Revisions=+25% | Analysts=2
EPS current Year (2026-06-30): EPS=-0.45 | Chg30d=+7.65% | Revisions=+25% | GrowthEPS=-25.7% | GrowthRev=+0.0%
EPS next Year (2027-06-30): EPS=-0.24 | Chg30d=+6.42% | Revisions=+0% | GrowthEPS=+46.2% | GrowthRev=+0.0%
[Analyst] Revisions Ratio: +29% (up=3, down=1)